The proportion of vessels involved (PSMA%) showed elevated results (grade 2–3) in 14/17 patients with a positive PSMA-PET/CT (Figure 6b): 13 ccRCC and 1 chromofobe RCC. This evidence concerns the gene FOLH1 and renal cell adenocarcinoma.